Media Summary: Yahoo Finance's Anjalee Khemlani joins the Meg Tirrell joins 'Closing Bell' to report Yahoo Finance's Anjalee Khemlani breaks down the latest news

Vaccine Watch Johnson And Johnson Moves Forward In Vaccine Trials - Detailed Analysis & Overview

Yahoo Finance's Anjalee Khemlani joins the Meg Tirrell joins 'Closing Bell' to report Yahoo Finance's Anjalee Khemlani breaks down the latest news Centers for Disease Control and Prevention A new study claims that the antibodies created through the Dr. Sara Andrabi, Assistant Professor of Emergency Medicine at Baylor College of Medicine, joins Yahoo Finance's Zack Guzman ...

Photo Gallery

Vaccine Watch: Johnson and Johnson moves forward in vaccine trials
Johnson & Johnson starts phase 3 coronavirus vaccine trial
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
Vaccine Watch: Inside Johnson & Johnson
Coronavirus vaccine: Pfizer, Johnson & Johnson take steps forward with vaccine trials
Johnson & Johnson will restart its Covid-19 phase 3 vaccine trial: Report
Johnson & Johnson in third phase COVID-19 vaccine trial
Coronavirus vaccine: Johnson and Johnson begins human vaccine trials for single shot vaccine
Johnson & Johnson vaccine in phase I/II human trials in U.S. and Belgium
CDC greenlights Johnson & Johnson Covid-19 vaccine
Behind The Scenes Of Johnson & Johnson’s Vaccine Trials | TODAY
Johnson & Johnson in Phase 3 of one-dose vaccine trial
Sponsored
Sponsored
View Detailed Profile
Vaccine Watch: Johnson and Johnson moves forward in vaccine trials

Vaccine Watch: Johnson and Johnson moves forward in vaccine trials

ABC News' Bob Woodruff reports

Johnson & Johnson starts phase 3 coronavirus vaccine trial

Johnson & Johnson starts phase 3 coronavirus vaccine trial

Johnson

Sponsored
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

The study of

Vaccine Watch: Inside Johnson & Johnson

Vaccine Watch: Inside Johnson & Johnson

ABC News' Bob Woodruff looks into

Coronavirus vaccine: Pfizer, Johnson & Johnson take steps forward with vaccine trials

Coronavirus vaccine: Pfizer, Johnson & Johnson take steps forward with vaccine trials

Yahoo Finance's Anjalee Khemlani joins the

Sponsored
Johnson & Johnson will restart its Covid-19 phase 3 vaccine trial: Report

Johnson & Johnson will restart its Covid-19 phase 3 vaccine trial: Report

Meg Tirrell joins 'Closing Bell' to report

Johnson & Johnson in third phase COVID-19 vaccine trial

Johnson & Johnson in third phase COVID-19 vaccine trial

Johnson

Coronavirus vaccine: Johnson and Johnson begins human vaccine trials for single shot vaccine

Coronavirus vaccine: Johnson and Johnson begins human vaccine trials for single shot vaccine

Yahoo Finance's Anjalee Khemlani breaks down the latest news

Johnson & Johnson vaccine in phase I/II human trials in U.S. and Belgium

Johnson & Johnson vaccine in phase I/II human trials in U.S. and Belgium

Johnson

CDC greenlights Johnson & Johnson Covid-19 vaccine

CDC greenlights Johnson & Johnson Covid-19 vaccine

Centers for Disease Control and Prevention

Behind The Scenes Of Johnson & Johnson’s Vaccine Trials | TODAY

Behind The Scenes Of Johnson & Johnson’s Vaccine Trials | TODAY

After it was briefly halted last month,

Johnson & Johnson in Phase 3 of one-dose vaccine trial

Johnson & Johnson in Phase 3 of one-dose vaccine trial

Johnson

AstraZeneca and Johnson & Johnson resume Phase 3 vaccine trials

AstraZeneca and Johnson & Johnson resume Phase 3 vaccine trials

AstraZeneca and

Coronavirus vaccine: Johnson and Johnson CFO discusses phase 1 trial, human testing, plus earnings

Coronavirus vaccine: Johnson and Johnson CFO discusses phase 1 trial, human testing, plus earnings

Johnson

Johnson & Johnson pauses COVID-19 vaccine trial

Johnson & Johnson pauses COVID-19 vaccine trial

A coronavirus

Johnson & Johnson Covid Vaccine Begins Rolling Out | NBC Nightly News

Johnson & Johnson Covid Vaccine Begins Rolling Out | NBC Nightly News

The first doses of

In-Depth: New study on Johnson & Johnson vaccine efficacy

In-Depth: New study on Johnson & Johnson vaccine efficacy

A new study claims that the antibodies created through the

Johnson & Johnson Covid Vaccine 72 Percent Effective In U.S. | NBC Nightly News

Johnson & Johnson Covid Vaccine 72 Percent Effective In U.S. | NBC Nightly News

Johnson

Coronavirus vaccine: Phases of vaccine trials explained, why J&J paused trials, plus Trump concerns

Coronavirus vaccine: Phases of vaccine trials explained, why J&J paused trials, plus Trump concerns

Dr. Sara Andrabi, Assistant Professor of Emergency Medicine at Baylor College of Medicine, joins Yahoo Finance's Zack Guzman ...

Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials

Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials

Johnson